Progress: Procedure completed
| Role | Committee | Rapporteur | Shadows |
|---|---|---|---|
| Lead | ENVI |
ARENA Maria ( S&D),
METZ Tilly ( Verts/ALE),
HAZEKAMP Anja ( GUE/NGL)
|
Lead committee dossier:
Legal Basis:
RoP 112-p2
Legal Basis:
RoP 112-p2Events
The European Parliament adopted by 407 votes to 256, with 24 abstentions, a resolution objecting to the Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances including chlorotoluron and difenoconazole.
The approval period for the active substance chlorotoluron has been once again extended by one year which extends the approval period until 31 October 2022.
Members recalled that chlorotoluron has a harmonised classification of very toxic to aquatic life, very toxic to aquatic life with long lasting effects, suspected of causing cancer (Carc. 2) and suspected of damaging the unborn child.
Parliament considered that that Implementing Regulation (EU) 2021/1449 exceeds the implementing powers provided for in Regulation (EC) No 1107/2009 concerning the placing of plant protection products on the market. It considered that the decision to extend the approval periods for chlorotoluron and difenoconazole is not in line with the safety criteria laid down in Regulation (EC) No 1107/2009 and is based neither on evidence that those substances can be used safely, nor on a proven urgent need for those substances in food production in the Union.
The Commission is called on to:
- repeal Implementing Regulation (EU) 2021/1449 and to submit a new draft to the committee, which takes into account the scientific evidence on the harmful properties of all the substances concerned, especially of chlorotoluron and difenoconazole;
- only present draft implementing regulations to extend the approval periods of substances for which the current state of science is not expected to lead to a Commission proposal for non-renewal of the approval of the active substance concerned;
- withdraw the approvals for substances if proof or reasonable doubt exists that they will not meet the safety criteria laid down in Regulation (EC) No 1107/2009.
Lastly, Member States should ensure the proper and timely reassessment of the approvals for the active substances for which they are the reporting Member States, and to ensure that current delays are solved effectively and as soon as possible.
Documents
- Commission response to text adopted in plenary: SP(2021)735
- Decision by Parliament: T9-0409/2021
- Motion for a resolution: B9-0481/2021
- Results of vote in Parliament: Results of vote in Parliament
- Motion for a resolution: B9-0481/2021
- Commission response to text adopted in plenary: SP(2021)735
Activities
Votes
Objection en vertu de l’article 112, paragraphes 2 et 3, du règlement intérieur: substances actives, dont le chlorotoluron et le difénoconazole - Objection pursuant to Rule 112(2) and (3): Active substances, including chlorotoluron and difenoconazole - Einwand gemäß Artikel 112 Absätze 2 und 3 GO: Wirkstoffe, einschließlich Chlortoluron und Difenoconazol - B9-0481/2021 - Proposition de résolution (ensemble du texte) #
Renew
ID
The Left
NI
ECR
PPEHistory
(these mark the time of scraping, not the official date of the change)
| docs/1 |
|
| events/0 |
|
| events |
|
| procedure/stage_reached |
Old
Awaiting plenary debate/voteNew
Procedure completed |
| forecasts |
|
| procedure/title |
Old
Objection pursuant to Rule 112(2) and (3) to Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances, including chlorotoluron and difenoconazoleNew
Resolution on Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron |
| docs |
|
| forecasts/0 |
|
| forecasts/0 |
|